Issue
Copyright (c) 2026 Nina Pestereva, Dmitrii Traktirov, Viktoria Burdinskaya, Ekaterina Kulikova, Timur Akbarov, Zamira Muruzheva, Marina Karpenko

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.Regulation of calpain 1 and calpain 2 activity by dopamine in rat brain regions
Corresponding Author(s) : Nina Pestereva
Cellular and Molecular Biology,
Vol. 72 No. 2: Issue 2
Abstract
Calpains are involved in regulating various brain functions. Limited proteolysis regulates cell proliferation, apoptosis, synaptic plasticity, long-term potentiation, and cell signaling. These are only some of the processes regulated by calpains. The current study reveals previously unexplored states of calpain activation associated with disorders of the dopaminergic system, including both hyperfunctional and hypofunctional states. In addition, activation of calpain 1 and calpain 2 affects the functioning of the central nervous system differently. Thus, this work aimed to study the effect of dopamine deficiency or excess on the activity of calpain 1 and calpain 2 in various parts of the central nervous system. We used L-dopa administration and DAT-KO rats to model a hyperdopaminergic state, and AMPT and reserpine to model a hypodopaminergic state. Dopamine deficiency causes: increased activity of calpain 1 in the striatum after AMPT administration; decreased activity of calpain 2 in the hippocampus after L-dopa administration. Excess dopamine causes: increased activity of calpains 1 and 2 in the striatum after L-dopa administration; decreased activity of calpains 1 and 2 in the midbrain after reserpine administration. Our data show that DAT knockout is associated with increased dopamine levels and increased activity of calpain 2 in the hippocampus, as well as decreased dopamine levels in the striatum and in the midbrain, accompanied by increased calpain 1 activity in the striatum.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX